Clinical Trial Update: Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TAK-875 (fasiglifam) in adults with Type 2 diabetes mellitus has completed, reporting on efficacy and safety. The update summarizes stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TAK-875 (fasiglifam)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED